Slides: SGLT2 inhibition in cardiology: What is the profile of benefit?
Presentation Prof. Nikolaus Marx
This lecture by prof. Nikolaus Marx was part of a CME accredited symposium Targeting SGLT2 in clinical cardiology: Exploring the benefits in CV risk, diabetes & heart failure held during ESC Congress 2018 in Munich
View presentation slides
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.